Ro Khanna @RoKhanna
The Bristol-Myers Squibb merger with Celgene will allow them to control even more of the market for cancer drugs. This could lead to even higher drug prices. With the Prescription Drug Price Relief Act, if Big Pharma keeps hiking the prices, we will check their monopoly power. — PolitiTweet.org